Transcatheter Aortic Valve Implantation (TAVI)
Treatments | Aortic Valve Repair and Replacement | Endovascular Stent Graft and Hybrid Procedures | Homograft | Minimally Invasive Aortic Surgery | Ross Procedure |
Transcatheter Valve Therapies
Transcatheter Valve Therapies
Who is a candidate for TAVI?
Standard surgical aortic valve replacement continues to be associated with high-quality outcomes and remains the gold standard for treatment of severe aortic stenosis. However, percutaneous and catheter based procedures are available for patients who are not candidates for surgical replacement.
Candidates for this percutaneous procedure include patients with severe symptomatic aortic stenosis and are deemed inoperable by a heart surgeon. "Inoperability" has no single definition but most commonly it is defined as a patient who faces more than a 50% risk of death or severe morbidity following a standard, surgical aortic valve replacement.
Candidates typically have one or more of the following characteristics:
What are the potential benefits of TAVI?
The New England Journal of Medicine recently reported that, in patients with severe symptomatic aortic stenosis who are not candidates for surgery, TAVI (aka TAVR) is associated significantly improved survival, improved symptoms, and improved quality of life compared to standard treatment. In fact, patients undergoing TAVI were nearly twice as likely to be alive at 1 year compared with those who did not.
What information is needed before I can undergo the procedure?
Evaluation includes assessment of the aortic valve, peripheral vasculature, aortic calcification, coronary disease, hemodynamics, cardiac function, lung function, and frailty.
Call our Valve Team at (855) 808-8223 or email firstname.lastname@example.org for more information.
In the News
Team effort key to first post-FDA approval TAVI case in Chicago
Dr. Milner discusses the benefits of collaboration in the management of aortic disease
The University of Chicago manages of severe aortic insufficiency in an LVAD patient using a percutaneous approach
What is aortic valve stenosis? Aortic valve stenosis (AS) is a disease of the aortic valve in which the opening of the . . .
How common is aortic valve stenosis? Approximately 2% of people over the age of 65. . .
Information for Patients
Information for Physicians
A Patient Experience with TAVI
- Univ of Chicago first in Chicago to perform post-trial transcatheter aortic valve replacement
- FDA Approval of Edwards SAPIEN Transcatheter Heart Valve (External Site)
- NEJM: Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery (External Site)
- First U.S. Transcatheter Replacement of a Pulmonary Valve Performed at University of Chicago Comer Children's Hospital
- Animation of transfemoral approach to transcatheter aortic valve implantation. (Courtesy of Edwards Lifesciences.) [58 seconds] (External Site)
- Connie describes her experience with aortic stenosis and transcatheter aortic valve implantation
- The University of Chicago announces successful management of severe aortic insufficiency in an LVAD patient using a totally percutaneous approach.